Identification of genes associated with progression and metastasis of advanced cervical cancers after radiotherapy by cDNA microarray analysis.

PURPOSE To identify a set of genes related to the progression and metastasis of advanced cervical cancer after radiotherapy and to establish a predictive method. METHODS AND MATERIALS A total of 28 patients with cervical cancer (15 stage IIIB, 13 stage IVA patients) who underwent definitive radiotherapy between May 1995 and April 2001 were included in this study. All patients were positive for human papillomavirus infection and harbored the wild-type p53 gene. The expression profiles of 14 tumors with local failure and multiple distant metastasis and 14 tumors without metastasis (cancer free) obtained by punch biopsy were compared before treatment, using a cDNA microarray consisting of 23,040 human genes. RESULTS Sixty-three genes were selected on the basis of a clustering analysis, and the validity of these genes was confirmed using a cross-validation test. The most accurate prediction was achieved for 63 genes (sensitivity, 78.8%; specificity, 38.1%). Some of these genes were already known to be associated with metastasis via chromosomal instability (TTK, BUB1B), extracellular matrix components (matrix metalloproteinase 1 [MMP-1]), and carcinogenesis (protein phosphatase 1 regulatory subunit 7 [PPP1R7]). A "predictive score" system was developed that could predict the probability for development of metastases using leave-one-out cross-validation methods. CONCLUSIONS The present results may provide valuable information for identified predictive markers and novel therapeutic target molecules for progression and metastasis of advanced cervical cancer.

[1]  I. Jacobs,et al.  A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer , 2002, British Journal of Cancer.

[2]  E. Nigg,et al.  Role of Hec1 in Spindle Checkpoint Signaling and Kinetochore Recruitment of Mad1/Mad2 , 2002, Science.

[3]  Yutaka Shimada,et al.  Prediction of Lymph Node Metastasis with Use of Artificial Neural Networks Based on Gene Expression Profiles in Esophageal Squamous Cell Carcinoma , 2004, Annals of Surgical Oncology.

[4]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Mansukhani,et al.  Genetic analysis identifies putative tumor suppressor sites at 2q35–q36.1 and 2q36.3–q37.1 involved in cervical cancer progression , 2003, Oncogene.

[6]  Y. Harima,et al.  Expression of Ku80 in Cervical Cancer Correlates With Response to Radiotherapy and Survival , 2003, American journal of clinical oncology.

[7]  P. Flemming,et al.  MMP-1 and MMP-2 in the cervix uteri in different steps of malignant transformation--an immunohistochemical study. , 2002, Gynecologic oncology.

[8]  T Tanaka,et al.  Identification by cDNA microarray of genes involved in ovarian carcinogenesis. , 2000, Cancer research.

[9]  E. Kubista,et al.  cDNA array analysis of cytobrush-collected normal and malignant cervical epithelial cells: a feasibility study. , 2005, Cancer genetics and cytogenetics.

[10]  A. Okamoto,et al.  Genetic alterations and expression of the protein phosphatase 1 genes in human cancers. , 2001, International journal of oncology.

[11]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[12]  Y. Harima,et al.  Loss of heterozygosity on chromosome 6p21.2 as a potential marker for recurrence after radiotherapy of human cervical cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  T. Inoue,et al.  Matrix metalloproteinase-1 expression is a prognostic factor for patients with advanced gastric cancer. , 1999, International journal of molecular medicine.

[14]  Y. Harima,et al.  Bax and Bcl-2 expressions predict response to radiotherapy in human cervical cancer , 1998, Journal of Cancer Research and Clinical Oncology.

[15]  L. Hefler,et al.  Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage IB cervical cancer. , 1999, Anticancer research.

[16]  Wei Zhang,et al.  Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  M. Jackson,et al.  Gene expression profiles of laser-captured adjacent neuronal subtypes , 1999, Nature Medicine.

[18]  Philip Lijnzaad,et al.  An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas , 2005, Nature Genetics.

[19]  S. Gayther,et al.  Molecular profiling of cervical cancer progression , 2007, British Journal of Cancer.

[20]  José A García,et al.  Gene identification by cDNA arrays in HPV-positive cervical cancer. , 2005, Archives of medical research.

[21]  I. Sekine,et al.  Expression of the MMP-1 in human pancreatic carcinoma: relationship with prognostic factor. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[22]  Song-Tao Liu,et al.  Human MPS1 kinase is required for mitotic arrest induced by the loss of CENP-E from kinetochores. , 2003, Molecular biology of the cell.

[23]  Y. Kitamoto,et al.  Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma. , 2004, International journal of radiation oncology, biology, physics.

[24]  J. Lee,et al.  Synchronous Coexpression of Epidermal Growth Factor Receptor and Cyclooxygenase-2 in Carcinomas of the Uterine Cervix , 2004, Clinical Cancer Research.

[25]  J. Quigley,et al.  Matrix metalloproteinases and tumor metastasis , 2006, Cancer and Metastasis Reviews.

[26]  J. McKay,et al.  Matrix metalloproteinase‐1 is associated with poor prognosis in oesophageal cancer , 1998, The Journal of pathology.

[27]  Jose Jeronimo,et al.  Human papillomavirus and cervical cancer , 2007, The Lancet.

[28]  Erich A. Nigg,et al.  Cell division: Mitotic kinases as regulators of cell division and its checkpoints , 2001, Nature Reviews Molecular Cell Biology.

[29]  H. Ishikawa,et al.  The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with Stage IIIB cervical carcinoma treated with radiation therapy alone , 2001, Cancer.

[30]  Giu-Cheng Hsu,et al.  Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility. , 2006, Carcinogenesis.

[31]  Lionel Arnaud,et al.  Human Mps1 kinase is required for the spindle assembly checkpoint but not for centrosome duplication , 2002, The EMBO journal.

[32]  Yusuke Nakamura,et al.  Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. , 2002, Neoplasia.

[33]  M. Bittner,et al.  A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma. , 2007, Cancer research.